Akesogen, Inc.
Tempus Labs, Inc.
- UEI
- DCNEWAMUCPB4
- CAGE
- 6FRL1
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 541714 Research and Development in Biotechnology (except Nanobiotechnology) Primary
- 493120 Refrigerated Warehousing and Storage
- 541380 Testing Laboratories and Services
- 541690 Other Scientific and Technical Consulting Services
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- 541990 All Other Professional, Scientific, and Technical Services
- 621511 Medical Laboratories
- SAM.gov registration date
- Website
- tempus.com
- Founded
- 2015
- Employees
- 1K-5K
- Estimated annual revenue
- $500M-$1B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Genomic analysis | Veterans Integrated Service Network 4 | $4,000,000 | |
| Genomic analysis | Veterans Integrated Service Network 4 | $4,000,000 | |
| Genomic analysis | Veterans Integrated Service Network 4 | $6,400,000 | |
| Genomic analysis | Veterans Integrated Service Network 4 | $13,020,379 | |
| Genomic analysis | Veterans Integrated Service Network 4 | $10,477,739 |
About Akesogen, Inc.
Akesogen, Inc., operating through its Tempus Labs, Inc. division, is a for-profit corporate entity registered in SAM.gov since 2011, specializing in advanced genomic analysis and molecular research services. The company is primarily focused on providing sophisticated scientific and technological services to federal agencies, with a significant concentration on biomedical research initiatives. Although specific details about the company's broader corporate profile are not available in the provided documentation, its primary federal contract work is centered on genomic research and analysis.
Akesogen, Inc.'s Tempus Labs, Inc. division has exclusively performed genomic analysis services for the U.S. Department of Veterans Affairs (VA) Headquarters through a series of firm fixed-price delivery order contracts. These contracts are part of a larger $111 million Indefinite Delivery Contract (IDC) awarded in 2020, supporting the VA's Million Veteran Program. The company's services include genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular testing services. The contract awards, ranging from $4 million to $13 million, have been consistently non-set-aside and focused on supporting biomedical research involving the analysis of over 800,000 veteran DNA samples. The work is performed at VA Headquarters in Washington, D.C., with contract periods typically spanning two years and completion dates ranging from September 2022 to March 2026.
Quick answers
What is Akesogen, Inc.'s UEI?
Akesogen, Inc.'s Unique Entity ID (UEI) in SAM.gov is DCNEWAMUCPB4.
What is Akesogen, Inc.'s CAGE code?
Akesogen, Inc.'s CAGE code is 6FRL1.
What is Akesogen, Inc.'s primary NAICS code?
Akesogen, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Is Akesogen, Inc. registered in SAM.gov?
Akesogen, Inc.'s SAM.gov registration expired on July 24, 2024.
What is Akesogen, Inc.'s most recent federal award?
Akesogen, Inc.'s most recent federal contract award is Genomic analysis (36C24E25N0255), from Veterans Integrated Service Network 4, on September 30, 2025.
On GovTribe
See Akesogen, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors